# Photronics Inc: Form 10-Q for the period ended Apr 29, 2018

- Company: [Photronics Inc](/companies/plab.md) (CIK 810136)
- Form: 10-Q
- Filed: 2018-06-05
- Accepted by EDGAR: Jun 5, 2018, 16:28 ET
- Period: 2018-04-29
- Accession: 0001140361-18-027356
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/810136/000114036118027356/form10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/810136/000114036118027356/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2018-04-29.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Gross profit | 3 months, 2018-01-29 to 2018-04-29 | $32.8m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2017-10-30 to 2018-04-29 | $60.5m | us-gaap:GrossProfit |
| Research and development | 3 months, 2018-01-29 to 2018-04-29 | $3.8m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2017-10-30 to 2018-04-29 | $7.9m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2018-01-29 to 2018-04-29 | $13.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2017-10-30 to 2018-04-29 | $25.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2018-01-29 to 2018-04-29 | $15.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2017-10-30 to 2018-04-29 | $27.2m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2018-01-29 to 2018-04-29 | $3.5m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2017-10-30 to 2018-04-29 | $1.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2018-01-29 to 2018-04-29 | $10.7m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2017-10-30 to 2018-04-29 | $16.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2018-01-29 to 2018-04-29 | $0.15 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2017-10-30 to 2018-04-29 | $0.23 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2018-01-29 to 2018-04-29 | $0.15 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2017-10-30 to 2018-04-29 | $0.24 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2018-01-29 to 2018-04-29 | 75,190,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2017-10-30 to 2018-04-29 | 75,052,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2017-10-30 to 2018-04-29 | $37.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2017-10-30 to 2018-04-29 | $44.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2018-04-29 | $321.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2018-04-29 | $500.3m | us-gaap:AssetsCurrent |
| Total assets | at 2018-04-29 | $1.10bn | us-gaap:Assets |
| Current liabilities | at 2018-04-29 | $166.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2018-04-29 | $184.2m | us-gaap:Liabilities |
| Shareholders' equity | at 2018-04-29 | $783.4m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 26,962 characters.

### Overview

Management's discussion and analysis ("MD&A") of the Company's financial condition, results of operations and outlook should be read in conjunction with its condensed consolidated financial statements and related notes. Various segments of this MD&A contain forward-looking statements, all of which are presented based on current expectations, which may be adversely affected by uncertainties and risk factors (presented throughout this filing and in the Company's Annual Report on Form 10-K for the fiscal 2017 year), that may cause actual results to materially differ from these expectations.

We sell substantially all of our photomasks to semiconductor and Flat Panel Display (“FPD”) designers and manufacturers. Photomask technology is also being applied to the fabrication of other higher performance electronic products such as photonics, micro-electronic mechanical systems and certain nanotechnology applications. Our selling cycle is tightly interwoven with the development and release of new semiconductor and FPD designs and applications, particularly as they relate to the microelectronic industry's migration to more advanced product innovation, design methodologies and fabrication processes. We believe that the demand for photomasks primarily depends on design activity rather than sales volumes from products manufactured using photomask technologies. Consequently, an increase in semiconductor or FPD sales does not necessarily result in a corresponding increase in photomask sales. However, the reduced use of customized Integrated Circuits (“ICs”), reductions in design complexity, other changes in the technology or methods of manufacturing or designing semiconductors, or a slowdown in the introduction of new semiconductor or FPD designs could reduce demand for photomasks ‒ even if the demand for semiconductors and FPDs increases. Advances in semiconductor, FPD and photomask design and semiconductor and FPD production methods that shift the burden of achieving device performance away from lithography could also reduce the demand for photomasks. Historically, the microelectronic industry has been volatile, experiencing periodic downturns and slowdowns in design activity. These downturns have been characterized by, among other things, diminished product demand, excess production capacity and accelerated erosion of selling prices.

We are typically required to fulfill customer orders within a short period of time, sometimes within 24 hours. This results in a minimal level of backlog orders, typically one to two weeks of backlog for IC photomasks and two to three weeks of backlog for FPD photomasks.

The global semiconductor and FPD industries are driven by end markets which have been closely tied to consumer-driven applications of high performance devices, including, but not limited to, mobile display devices, mobile communications, and computing solutions. While we cannot predict the timing of the industry's transition to volume production of next-generation technology nodes, or the timing of up and down cycles with precise accuracy, we believe that such transitions and cycles will continue into the future, beneficially and adversely affecting our business, financial condition and operating results as they occur. We believe our ability to remain successful in these environments is dependent upon the achievement of our goals of being a service and technology leader and efficient solutions supplier, which we believe should also enable us to continually reinvest in our global infrastructure.

In the first quarter of fiscal 2018, we announced the successful closing of the China joint venture agreement with Dai Nippon Printing Co., Ltd. (“DNP”), which we had agreed to enter into and announced in the third quarter of fiscal 2017. Under the agreement, our wholly-owned Singapore subsidiary owns 50.01% of the joint venture, which is named Photronics DNP Mask Corporation Xiamen (PDMCX), and a subsidiary of DNP owns the remaining 49.99%. The financial results of the joint venture are included in the Photronics, Inc. consolidated financial statements. See Note 5 of the condensed consolidated financial statements for additional information on the joint venture.

In the fourth quarter of fiscal 2017, we announced that Photronics UK, Ltd., our wholly owned subsidiary, signed an investment agreement with the Hefei State Hi-tech Industry Development Zone to establish a manufacturing facility in Hefei, China. Under the terms of the agreement, through our subsidiary, we will invest a minimum of $160 million, a portion of which may be funded with local borrowings, to build and operate a research and development and manufacturing facility for high-end and mainstream FPD photomasks. The Hefei State Hi-tech Industry Development Zone will provide certain investment incentives and support for this facility, which will have initial capability to produce up to G10.5+ large area masks and AMOLED products. Construction began in late 2017 and production is anticipated to commence during the first half of 2019.

In the fourth quarter of fiscal 2016, Photronics Singapore Pte, Ltd., a wholly owned subsidiary, signed an investment agreement with the Administrative Committee of Xiamen Torch Hi-Tech Industrial Development Zone (Xiamen Torch) to establish an IC manufacturing facility in Xiamen, China. Under the terms of the agreement, we will build and operate an IC facility to engage in research and development, manufacture and sale of photomasks, in return for which Xiamen Torch will provide certain investment incentives and support. This expansion is also substantially supported by customer commitments for its output. As discussed above, in the first quarter of fiscal 2018, we entered into a joint venture agreement with DNP, under which they obtained a 49.99% ownership interest in this facility. The total investment, per the agreement, is $160 million to be funded over the next several years with cash and local borrowings. Construction began in 2017 and production is anticipated to start during the first half of 2019.

### Material Changes in Results of Operations

### Three and Six Months ended April 29, 2018 and April 30, 2017

The following table presents selected operating information expressed as a percentage of revenue.

|  | Three Months Ended April 29, 2018 | January 28, 2018 | April 30, 2017 | Six Months Ended April 29, 2018 | April 30, 2017 |
| --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | (74.9) | (77.6) | (81.4) | (76.2) | (80.2) |
| Gross profit | 25.1 | 22.4 | 18.6 | 23.8 | 19.8 |
| Selling, general and administrative expenses | (10.4) | (9.5) | (10.1) | (10.0) | (10.0) |
| Research and development expenses | (2.9) | (3.3) | (3.4) | (3.1) | (3.3) |
| Operating income | 11.8 | 9.6 | 5.1 | 10.7 | 6.5 |
| Other income (expense), net | 2.5 | (3.4) | (3.3) | (0.3) | (2.6) |
| Income before income taxes | 14.3 | 6.2 | 1.8 | 10.4 | 3.9 |
| Income tax (provision) benefit | (2.7) | 1.5 | (0.4) | (0.7) | (1.2) |
| Net income | 11.6 | 7.7 | 1.4 | 9.7 | 2.7 |
| Net (income) loss attributable to noncontrolling interests | (3.4) | (2.9) | 0.3 | (3.2) | (1.0) |
| Net income attributable to Photronics, Inc. shareholders | 8.2% | 4.8% | 1.7% | 6.5% | 1.7% |

Note: All of the following tabular comparisons, unless otherwise indicated, are for the three months ended April 29, 2018 (Q2 FY18), January 28, 2018 (Q1 FY18) and April 30, 2017 (Q2 FY17) and for the six months ended April 29, 2018 (YTD FY18) and April 30, 2017 (YTD FY17), in millions of dollars.

### Revenue

The following tables present revenue changes by product type and technology level:

| IC | Q2 FY18 compared with Q1 FY18 Revenue in Q2 FY18 | Percent Change | Increase (Decrease) | Q2 FY18 compared with Q2 FY17 Percent Change | Increase (Decrease) | YTD FY18 compared with YTD FY17 Revenue in YTD FY18 | Percent Change | Increase (Decrease) |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| High-end | $41.5 | 24.2% | $8.1 | 82.7% | $18.8 | $74.8 | 66.8% | $30.0 |
| Mainstream | 60.8 | (2.4)% | (1.5) | 1.4% | 0.8 | 123.1 | (0.9)% | (1.1) |
| Total IC | $102.3 | 6.9% | $6.6 | 23.7% | $19.6 | $197.9 | 17.1% | $28.9 |
| FPD |  |  |  |  |  |  |  |  |
| High-end | $18.2 | (2.9)% | $(0.6) | 8.8% | $1.5 | $37.0 | 8.9% | $3.0 |
| Mainstream | 10.3 | 14.5% | 1.3 | 15.7% | 1.4 | 19.3 | 27.8% | 4.2 |
| Total FPD | $28.5 | 2.7% | $0.7 | 11.2% | $2.9 | $56.3 | 14.7% | $7.2 |
| Total Revenue | $130.8 | 5.9% | $7.3 | 20.8% | $22.5 | $254.2 | 16.5% | $36.1 |

22

In Q1 FY18, we changed the threshold for the definition of high-end IC, from 45 nanometer or smaller to 28 nanometer or smaller, to reflect the overall advancement of technology in the semiconductor industry. All comparisons to prior period results in this MD&A reflect this modification. Our definition of high-end FPD products remains as G8 and above and active matrix organic light-emitting diode (AMOLED) display screens. High-end photomasks typically have higher ASPs than mainstream products.

Our quarterly revenues can be affected by the seasonal purchasing tendencies of our customers. As a result, demand for our products is typically negatively impacted during the first, and sometimes the second, quarters of our fiscal year by the North American, European, and Asian holiday periods, as some of our customers reduce their development and, consequently, their buying activities during those periods.

The following tables compare revenue in Q2 FY18 with revenue in Q1 FY18 and Q2 FY17, and revenue YTD FY18 with YTD FY17 by geographic area:

|  | Q2 FY18 with Q1 FY18 Revenue in Q2 FY18 | Percent Change | Increase (Decrease) | Q2 FY18 with Q2 FY17 Percent Change | Increase (Decrease) | YTD FY18 with YTD FY17 Revenue in YTD FY18 | Percent Change | Increase (Decrease) |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Taiwan | $56.1 | (0.9)% | $(0.5) | 32.8% | $13.8 | $112.6 | 26.9% | $23.9 |
| Korea | 36.1 | 9.4% | 3.1 | 16.7% | 5.2 | 69.1 | 12.9% | 7.9 |
| United States | 29.2 | 16.7% | 4.2 | 12.5% | 3.3 | 54.2 | 9.4% | 4.6 |
| Europe | 8.7 | 3.1% | 0.2 | 0.4% | - | 17.2 | (1.2)% | (0.2) |
| Other | 0.7 | 82.7% | 0.3 | 36.5% | 0.2 | 1.1 | (10.3)% | (0.1) |
|  | $130.8 | 5.9% | $7.3 | 20.8% | $22.5 | $254.2 | 16.5% | $36.1 |

Revenue increased 5.9% in Q2 FY18 compared with Q1 FY18, as a result of high-end IC and mainstream FPD growth. That revenue increased 24.2% from Q1 FY18, due to growth in both logic and memory from the healthy foundry demand across Asia. IC mainstream, decreased 2.4%, as demand was slightly softer. FPD revenue increased 2.7% from Q1 FY18 due to increased demand from masks used in LTPS LCD displays, partially offset by a decrease in high-end FPD due to softness in AMOLED demand.

Revenue increased 20.8% in Q2 FY18 compared with Q2 FY17, primarily as a result of high-end IC growth. That revenue increased 82.7% from Q2 FY18, due to growth in both logic and memory from the healthy foundry demand across Asia. IC mainstream increased 1.4%, as demand was slightly stronger. FPD revenue increased 11.2% from Q2 FY17 due to better demand across our products and markets.

Revenue increased 16.5% in YTD Q2 2018 when compared with YTD Q2 2017, primarily as a result of high-end IC growth. That revenue increased 66.8% from YTD 2017, due to growth in both logic and memory from the healthy foundry demand across Asia. IC mainstream decreased 0.9%, as demand was slightly softer. FPD revenue increased 14.7% due to better demand across our products and markets.

We believe there is potential for the favorable demand trend we experienced in the first half of fiscal 2018 to continue through the third quarter, as we expect growth to continue across most of our high-end markets, although annual preventive maintenance on high-end lithography tools scheduled for the third quarter may somewhat constrain revenue growth. We also expect to benefit in the second half of the year from the installation and ramp of a high-end FPD mask writer in Korea. Our two China facilities are expected to begin production in the first half of 2019, and we anticipate that our sales and revenue will increase when they come online.

### Gross Profit

|  | Three Months Ended Q2 FY18 | Q1 FY18 | Percent Change | Q2 FY17 | Percent Change | Six Months Ended YTD FY18 | YTD FY17 | Percent Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Gross profit | $32.8 | $27.7 | 18.6% | $20.2 | 62.8% | $60.5% | $43.2 | 40.1% |
| Gross margin | 25.1% | 22.4% |  | 18.6% |  | 23.8% | 19.8% |  |

23

The increases in gross profit and gross margin from Q1 FY18 were driven by increased unit sales, which were up for both high-end and mainstream IC and FPD categories. A modest (2.3%) increase in cost of goods sold was primarily the result of increased labor costs.

Increases in high-end unit sales of both product categories were primarily responsible for the increase in gross profit and gross margin from Q2 FY17. Material and labor costs increased from the prior year’s quarter, primarily as a result of the increased in units sold and increased compensation costs.

Increased high-end IC and FPD unit sales were the main contributors to the improvement in gross profit and gross margin from YTD FY17, while ASPs of mainstream products – primarily FPDs – were also favorable. Costs, as a percent of revenue, were flat or decreased in all categories. As we operate in a high fixed cost environment, increases or decreases in our revenues and utilization will generally positively or negatively impact our gross margin.

### Selling, General and Administrative Expenses

Selling, general and administrative expenses increased by $1.9 million, or 16.1%, to $13.6 million in Q2 FY18, from $11.8 million in Q1 FY18, primarily due to increased compensation and selling expenses. Selling, general and administrative expenses increased in Q2 FY18 by $2.7 million, or 25.2%, to $13.7 million, from $10.9 million in Q2 FY17, primarily as a result of increased compensation, professional services, and freight expenses. On a year-to-date basis, selling, general and administrative expenses increased $3.6 million, or 16.6%, to $25.4 million from $21.8 million, primarily due to increases in professional fees, freight, compensation, and travel expenses, most of which increased as a result of activities related to our expansion into China.

### Research and Development

In the U.S., research and development expenses consist of development efforts related to high-end process technologies for 28nm and smaller IC nodes, while in Asia, in addition to the focus on high-end IC technology nodes, G8 and above FPDs and AMOLED applications are also under development.

Research and development expense decreased $0.3 million, or 7.0%, from Q1 FY18, as decreased expenditures, and related activities in the U.S. were somewhat offset by increased spending in Asia. Research and development expense was up moderately ($0.1 million, or 2.4%) from Q2 FY17, with increased spending in Asia (primarily Korea) exceeding decreased expenditures and related activities in the U.S. On a YTD basis, research and development expense increased $0.7 million, or 9.8%, as spending and related activities increased in both the U.S. and Asia.

### Other Income (Expense), net

|  | Three Months Ended Q2 FY18 | Q1 FY18 | Q2 FY17 | Six Months Ended YTD FY18 | YTD FY17 |
| --- | ---: | ---: | ---: | ---: | ---: |
| Interest income and other income (expense), net | $3.9 | $(3.5) | $(3.1) | $0.3 | $(4.6) |
| Interest expense | (0.6) | (0.6) | (0.5) | (1.1) | (1.1) |
| Other income (expense), net | $3.3 | $(4.1) | $(3.6) | $(0.8) | $(5.7) |

Interest income and other income (expense), net increased from Q1 FY18 by $7.4 million primarily due to favorable foreign currency exchange gains in the second quarter, in contrast to the losses incurred in the previous quarter, the net effect of which was $6.9 million. In addition, we recognized gains on the sale of certain assets of $0.6 million in Q2 FY18. Foreign currency exchange gains in the second quarter also contrasted with losses experienced in the prior year quarter, having a favorable net effect of $5.7 million on this line item. The aforementioned gains on the sale of certain assets also contributed to the favorability of the current quarter over Q2 FY17.

On a year-to-date basis, interest income and other income (expense), net increased as a result of $3.1 million of less unfavorable foreign currency exchange losses and the previously mentioned gains on the sale of certain assets.

### Income Tax (Provision) Benefit

|  | Three Months Ended Q2 FY18 | Q1 FY18 | Q2 FY17 | Six Months Ended YTD FY18 | YTD FY17 |
| --- | ---: | ---: | ---: | ---: | ---: |
| Income tax (provision) benefit | $(3.5) | $1.8 | $(0.4) | $(1.7) | $(2.5) |
| Effective income tax rate | 18.8% | (23.1)% | 22.5% | 6.5% | 29.3% |

The effective income tax rate is sensitive to the jurisdictional mix of earnings, due, in part, to the non-recognition of tax benefits on losses in jurisdictions with valuation allowances.

The effective income tax rate in Q2 FY18, compared with Q1 FY18, changed from a benefit to a provision, primarily due to the Q1 FY18 nonrecurring tax benefits ($4.2 million) related to tax reform in the US and Taiwan, that were partially offset by an increased benefit ($0.6 million) from the tax holiday in Taiwan. The effective income tax rate decreased in Q2 FY18, compared with Q2 FY17, primarily due to a lower percentage of income before taxes being generated in jurisdictions where the company incurs tax losses that, due to valuation allowances, did not result in the recognition of tax benefits.

The effective income tax rate decreased in YTD FY18, compared with YTD FY17, primarily due to a lower percentage of income before taxes being generated in jurisdictions where the company incurs tax loses that, due to valuation allowances, did not result in the recognition of tax benefits, and the Q1 FY18 nonrecurring tax benefits ($4.2 million) related to tax reform in the US and Taiwan, that were partially offset by an increased benefit ($0.6 million) from the tax holiday in Taiwan.

### Net (Income) Loss Attributable to Noncontrolling Interests

Net income attributable to noncontrolling interests was $4.5 million in Q2 FY18, which represented an increase of $0.9 million and an increase of $4.8 million from Q1 FY18 and Q2 FY17, respectively. Year-to-date, noncontrolling interests’ share increased $5.9 million from YTD FY17. The changes from all comparative periods were due to changes in net income at our IC manufacturing facility in Taiwan, in which we hold a 50.01% ownership interest.

### Liquidity and Capital Resources

Our working capital at the end of Q2 FY18 was $333.8 million, compared with $367.3 million at the end of Q4 FY17. The decrease is primarily attributable to the reclassification of our $57.5 million principal amount senior convertible notes to current status. Cash and cash equivalents increased in fiscal year 2018 by $13.2 million from $308.0 million at October 29, 2017. The favorable effects of foreign currency exchange rates contributed $6.3 million to the increase. Net cash provided by operating activities was $37.9 million in YTD FY18, compared with $46.9 million in YTD FY17, as increased net cash consumed by operating activities exceeded increases in both net income and noncash expenses by $9.0 million. Net cash used in investing activities was $43.7 million in YTD FY18, an increase of $23.8 million from the $19.8 million used in YTD FY17. The increase was primarily attributable to increased capital expenditures of $30.0 million; the increase attributable to higher CAPEX was partially offset by cash of $5.4 million used to acquire a business in YTD FY17 that was not repeated in FY18. Cash flows from financing activities increased from funds used of $0.4 million in YTD FY17 to $12.7 million provided in YTD FY18, primarily due to the receipt of $12.0 million from a noncontrolling interest for their investment in our recently established joint venture in China, and an increase in proceeds received from share-based arrangements of $1.5 million.

As of April 29, 2018 and October 29, 2017, total cash and cash equivalents included $183 million and $190.0 million, respectively, held by our foreign subsidiaries.

Our credit facility, which expires in December 2018, has a $50 million limit with an expansion capacity to $75 million, and is secured by substantially all of our assets located in the United States and the common stock of certain foreign subsidiaries. The credit facility is subject to a minimum interest coverage ratio, total leverage ratio and minimum unrestricted cash balance financial covenants, all of which we were in compliance with at April 29, 2018. We had no outstanding borrowings against the credit facility at April 29, 2018, and $50 million was available for borrowing. The interest rate on the credit facility (3.62% at April 29, 2018) is based on our total leverage ratio at LIBOR plus a spread, as defined in the credit facility.

As of April 29, 2018, we had capital commitments outstanding of approximately $176 million. We intend to finance our capital expenditures with our working capital, cash generated from operations, and, if necessary, additional borrowings. We have entered into a joint venture that is constructing an IC facility in China with an estimated total investment of $160 million. Our remaining funding commitment for the joint venture is approximately $68 million, over the next several years. We have also commenced construction of an FPD facility in China, in which we will invest $160 million over that same period. We believe that our cash on hand, cash generated from operations and amounts available to borrow will be sufficient to meet our cash requirements for the next twelve months. We regularly review the availability and terms at which we might issue additional equity or debt securities in the public or private markets. However, we cannot assure that additional sources of financing would be available to us on commercially favorable terms, should our capital requirements exceed our existing cash, cash generated by operations, and cash available under our credit facility.

Our liquidity, as we operate in a high fixed cost environment, is highly dependent on our revenue, cash conversion cycle, and the timing of our capital expenditures (which can vary significantly from period to period). Depending on conditions in the semiconductor and FPD markets, our cash flows from operations and current holdings of cash may not be adequate to meet our current and long-term needs for capital expenditures, operations and debt repayments. Historically, in certain years, we have used external financing to fund these needs. Due to conditions in the credit markets and covenant restrictions on our existing debt, some financing instruments we have used in the past may not be available to us when required. Consequently, we cannot assure that additional sources of financing would be available to us on commercially favorable terms, should our long-term cash requirements exceed our existing cash and cash available under our credit facility.

### Off-Balance Sheet Arrangements

In January 2018, Photronics, through its wholly-owned Singapore subsidiary, and DNP, through its wholly owned subsidiary “DNP Asia Pacific PTE, Ltd.” entered into a joint venture under which DNP obtained a 49.99% interest in our IC business in Xiamen, China. The joint venture, known as “Photronics DNP Mask Corporation Xiamen” ( “PDMCX”), was established to develop and manufacture photomasks for leading edge and advanced generation semiconductors. Under the Joint Venture Operating Agreement of Photronics DNP Mask Corporation Xiamen (“the Agreement”), DNP is afforded, under certain circumstances, the right to put its interest in PDMCX to Photronics. These circumstances include disputes regarding the strategic direction of PDMCX that arise after the initial two year term of the Agreement that cannot be resolved between the two parties. In addition, both Photronics and DNP have the option to purchase, or put, their interest from, or to, the other party, should their ownership interest fall below 20% for a period of more than six consecutive months. Under all such circumstances, the sales of ownership interests would be at the exiting party’s ownership percentage of the joint venture’s net book value, with closing to take place within three business days of obtaining required approvals and clearance. Should DNP exercise an option to put their, or purchase our, interest in PDMCX we may, depending on the relationship of the fair and book value of the net assets of PDMCX, incur a loss.

We lease certain office facilities and equipment under operating leases that may require us to pay taxes, insurance and maintenance expenses related to the properties. Certain of these leases contain renewal or purchase options exercisable at the end of the lease terms.

### Business Outlook

A majority of our revenue growth is expected to continue to come from the Asian region, predominantly in China. In response to this expectation, we have entered into a joint venture that will complete the construction of an IC research and development and manufacturing facility in Xiamen, China, in late 2018. Production is anticipated to begin at this facility during the first half of 2019. In addition, in August 2017, we entered into an investment agreement to construct an FPD manufacturing facility in Hefei, China. Construction of this facility commenced in Q1 FY18, and production is anticipated to begin during the first half of 2019.

We continue to assess our global manufacturing strategy and monitor our revenue and related cash flows from operations. This ongoing assessment could result in future facility closures, asset redeployments, additional impairments of intangible or long-lived assets, workforce reductions, or the addition of increased manufacturing facilities, all of which would be based on market conditions and customer requirements.

Our future results of operations and the other forward-looking statements contained in this filing involve a number of risks and uncertainties. While various risks and uncertainties were discussed in Part1, Item 1A in our Annual Report on Form 10-K for the year ended October 29, 2017, a number of other unforeseen factors could cause actual results to differ materially from our expectations.

### Effect of Recent Accounting Pronouncements

See “Item 1. Condensed Consolidated Financial Statements– Notes to Condensed Consolidated Financial Statements – Note 13 – Recent Accounting Pronouncements” for recent accounting pronouncements that may affect the Company’s financial reporting.

## Market risk

As filed, 2,406 characters.

### Foreign Currency Exchange Rate Risk

We conduct business in several major international currencies throughout our worldwide operations, and our financial performance may be affected by fluctuations in the exchange rates of these currencies. Changes in exchange rates can positively or negatively affect our reported revenue, operating income, assets, liabilities, and equity. The functional currencies of our Asian subsidiaries are the South Korean won, the New Taiwan dollar, the Chinese renminbi and the Singapore dollar. The functional currencies of our European subsidiaries are the British pound and the euro. In addition, we have transactions and balances in Japanese yen.

We attempt to minimize our risk of foreign currency transaction losses by producing products in the same country in which the products are sold (thereby generating revenues and incurring expenses in the same currency), and by managing our working capital. However, in some instances, we sell products in a currency other than the functional currency of the country where it was produced, or purchase products in a currency that differs from the functional currency of the purchasing manufacturing facility. There can be no assurance that this approach will protect us from the need to recognize significant foreign currency transaction gains and losses, especially in the event of a significant adverse movement in the value of any foreign currency in which we conduct business against any of our functional currencies, including the U.S. dollar.

As of April 29, 2018, a 10% adverse movement in the value of currencies different than the functional currencies of our subsidiaries would have resulted in a net unrealized pre-tax loss of $7.1 million, which represents a decrease of $8.9 million and $5.9 million from April 29, 2018 and October 29, 2017, respectively. The decrease in foreign currency exchange rate risk from both comparative balance sheet dates is primarily the result of decreased exposures to U.S. dollar and Japanese yen denominated exposures in Taiwan, and decreased exposure to U.S. dollar denominated exposures in China.

### Interest Rate Risk

At April 29, 2018, we did not have any variable rate borrowings. A 10% change in interest rates would not have had a material effect on our consolidated financial position, results of operations, or cash flows in the three month period ended April 29, 2018.

## Controls and procedures

As filed, 1,943 characters.

### Evaluation of Disclosure Controls and Procedures

We have established and currently maintain disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), designed to provide reasonable assurance that information required to be disclosed in its reports filed under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms, and that such information is accumulated and communicated to management, including our chief executive officer and chief financial officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Our management, under the supervision and with the participation of our chief executive officer and chief financial officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. Based upon that evaluation our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were effective at a reasonable assurance level as of the end of the period covered by this report.

### Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting during the second quarter of fiscal year 2018 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 1,523 characters.

The General Data Protection Regulation (GDPR), which went into effect in the European Union (EU) on May 25, 2018, applies to the collection, use, retention, security, processing, and transfer of personally identifiable information about residents of EU countries. The GDPR created a range of new compliance obligations, and imposes significant fines and sanctions for violations. It is possible that the GDPR may be interpreted or applied in a manner that is adverse to us, unforeseen by us, or otherwise inconsistent with our practices or that we may otherwise fail to construe its requirements in ways that are satisfactory to the EU authorities.

Any failure, or perceived failure, by us to comply with the GDPR or with any applicable regulatory requirements or orders, including but not limited to privacy, data protection, information security, or consumer protection-related privacy laws and regulations in one or more jurisdictions within the EU or elsewhere, could result in proceedings or actions against us by governmental entities or individuals, subject us to significant fines, penalties, and/or judgments, require us to change our business practices; limit access to our products and services in certain countries, or otherwise adversely affect our business, as we would be at risk to lose both customers and revenue, and incur substantial costs.

There have been no other material changes to risks relating to our business as disclosed in Part 1, Item 1A of our Form 10-K for the year ended October 29, 2017.

Filed Jun 5, 2018.
Source: SEC EDGAR, the filing index for accession 0001140361-18-027356. Last ingested by Listed: Nov 15, 2026, 01:00 ET. No prices; not investment advice.
